Prenetics and David Beckham Unite for IM8: A New Era in Health and Wellness Products

Prenetics and Beckham Launch IM8 for Health Innovation

Hong Kong-based biotechnology start-up Prenetics, alongside UK football star David Beckham, has officially launched their health and wellness brand IM8. This initiative introduces two premium products, Daily Ultimate Essentials and Daily Ultimate Longevity, available for online purchase and shipping across 31 countries, including the US, Hong Kong, UK, and Singapore.

The Vision behind IM8

Beckham expressed immense pride in the creation of IM8, stating that he personally uses the products, which have brought positive impacts on his health. The brand is committed to harnessing the best of science and innovation to empower individuals in managing their health and wellness.

What IM8 Offers

• Daily Ultimate Essentials is a comprehensive nutrient supplement, combining 16 essential daily supplements to foster heart and joint health.
• Daily Ultimate Longevity aims to support cellular rejuvenation and promote healthy aging.

The global health supplement industry is projected to grow from US$167.5 billion in 2023 to US$239.4 billion by 2028, driven by an aging population and increasing health awareness due to the recent Covid-19 pandemic.

Market Trends and Growth

The health supplements market in China alone was valued at US$45.5 billion in 2023, expected to rise to US$58.2 billion by 2027. This growth is fueled by heightened health consciousness and a growing demand for vitamins, herbal products, and weight management solutions.

Prenetics’ Expansion and Achievements

Prenetics has transformed from a small genetic testing lab into a major player in cancer diagnostics, partnering with notable figures like Dennis Lo Yuk-ming from the Li Ka Shing Institute of Health Sciences. Following the acquisition of Taiwan's ACT Genomics, Prenetics broadens its genomic testing capabilities.

Conclusion: A Strategic Move

As Prenetics narrows its losses and increases revenues, the launch of IM8 signals a strategic pivot towards health products, aligning with current market needs and consumer interests.